Initial Age and Performans Status: Predicators for Re-Irradiation Ability in Patients with Relapsed Brain Metastasis after Initial Stereotactic Radiotherapy.

Fiche publication

Date publication

juillet 2024

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NOEL Georges , Mme CHAMBRELANT Isabelle , Dr LE FEVRE Clara

Tous les auteurs :
Chambrelant I, Kuntz L, Le Fèvre C, Jarnet D, Jacob J, Noël G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39061240

Résumé

Brain metastases (BMs) frequently occur in cancer patients, and stereotactic radiation therapy (SRT) is a preferred treatment option. In this retrospective study, we analyzed patients treated by SRT for a single BM during their first SRT session and we compared two subgroups: "Cohort 1" with patients did not undergo cerebral re-irradiation and "Cohort 2" with patients received at least one subsequent SRT session for cerebral recurrence.